Cody Bly, M4 – UNTHSC TCOM 
“Protamine Considerations in Heparin Reversal”

OBJECTIVES:  As a result of this activity, the participant should be able to: 
1) Explain the mechanism of action and metabolism of protamine in heparin reversal. 2) List and describe the adverse effects of protamine administration.  3) Analyze the hemodynamic changes associated with protamine administration and subsequent treatment of adverse effects.

Grant Christensen, M4 - RFUMS
“The Use of Virtual Reality in Anesthesia”

OBJECTIVES:  As a result of this activity, the participant should be able to: 
1)  Discuss/Describe the basics of virtual reality in anesthesia.  2) Explain the benefits of virtual reality to patients and other providers. 3) Analyze the current research being used to explore virtual reality in anesthesia.

Freedom Ha, M4 – TTU Lubbock
“Remimazolam”

OBJECTIVES:  As a result of this activity, the participant should be able to:
1) Describe the current clinical use of Remimazolam.  2) List common dosing recommendations for Remimazolam.  3) Discuss some advantages and disadvantages of using Remimazolam.

Jordan Hartman, M4 – ATSU KCOM
“Nitrous Oxide-Related Post-OP Nausea and Vomiting”

OBJECTIVES:  As a result of this activity, the participant should be able to:
1) Identify Nitrous Oxide-related PONV risk factors.  2) Evaluate risk of PONV with use of Nitrous Oxide.  3) Explain prophylactic agents for patients with moderate to severe risk of PONV.

Trent McElroy, M4 – ATSU KCOM
“Bronchial Blockers for One Lung Ventilation”

OBJECTIVES:  As a result of this activity, the participant should be able to: 
1) Identify the common indications and methods used for one-lung ventilation (OLV) during surgery. 2) Describe the advantages/disadvantages of bronchial blockers (BB) compared to double-lumen tubes. 3) List the common models of bronchial blocker devices and describe placement techniques. 4) Summarize potential complications and management strategies associated with BBs and OLV during surgery.

Brayden Rucker, M4 - OSU
“Ketorolac for Postoperative Pain Management”

OBJECTIVES:  As a result of this activity, the participant should be able to: 
1) Describe how Ketorolac can be used in a multimodal analgesic regimen.   2) Review the literature regarding Ketorolac for postoperative pain.           3) Identify factors which prevent Ketorolac from being administered.

FACULTY DISCLOSURE:  Drs. Bly, Christensen, Ha, Hartman, McElroy and Rucker have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNERS DISCLOSURES:  William C Culp, MD, Craig Lilie, MD and Michael P Hofkamp have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.